Inamrinone
As of the edition of 20 October 2026, Inamrinone is a small molecule: marketed, first approved in 1984 (US); acts on PDE3A; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1984
- Kind
- Small molecule
- Brand name
- Inocor
- First approved
- 31 July 1984 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Sanofi
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| PDE3A | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A | Q14432 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Sanofi | Applicant | 1984 to now |